Shinichi Toyooka

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe et al. · The Lancet Oncology · 2009 · 4.1K citations

Open Label, Medicine, Cancer Growth +10

Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers

Hisayuki Shigematsu, Tsuyoshi Takahashi, Masatoshi Nomura et al. · JNCI Journal of the National Cancer Institute · 2005 · 2.4K citations

Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression

David G. Burbee, Éva Forgács, Sabine Zöchbauer‐Müller et al. · JNCI Journal of the National Cancer Institute · 2001 · 769 citations · Full text

Somatic Mutations of the <i>HER2</i> Kinase Domain in Lung Adenocarcinomas

Hisayuki Shigematsu, Takao Takahashi, Masaharu Nomura et al. · Cancer Research · 2005 · 672 citations

The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers

Masaki Tokumo, Shinichi Toyooka, Katsuyuki Kiura et al. · Clinical Cancer Research · 2005 · 495 citations · Full text